Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Clinical trial NCT07227818 · RECRUITING
Trial details
- NCT number
- NCT07227818
- Sponsor
- Neurocrine Biosciences
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-16
- Primary completion
- 2029-07-01
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.